0001104659-24-001950.txt : 20240105
0001104659-24-001950.hdr.sgml : 20240105
20240105210114
ACCESSION NUMBER: 0001104659-24-001950
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240103
FILED AS OF DATE: 20240105
DATE AS OF CHANGE: 20240105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blok Tyler
CENTRAL INDEX KEY: 0001990234
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-49908
FILM NUMBER: 24518097
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET
STREET 2: SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytoDyn Inc.
CENTRAL INDEX KEY: 0001175680
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 753056237
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
BUSINESS PHONE: 360-980-8524
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
FORMER COMPANY:
FORMER CONFORMED NAME: CYTODYN INC
DATE OF NAME CHANGE: 20031114
FORMER COMPANY:
FORMER CONFORMED NAME: REXRAY CORP
DATE OF NAME CHANGE: 20020617
4
1
tm242134-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-03
0
0001175680
CytoDyn Inc.
CYDY
0001990234
Blok Tyler
1111 MAIN STREET, SUITE 660
VANCOUVER
WA
98660
0
1
0
0
EVP of Legal Affairs
0
Common Stock
250
I
By Spouse
Non-qualified stock option (right to buy)
0.67
2024-01-03
4
D
0
100000
D
2032-07-25
Common Stock
100000
0
D
Non-qualified stock option (right to buy)
0.21
2024-01-03
4
A
0
100000
A
2032-07-25
Common Stock
100000
100000
D
Non-qualified stock option (right to buy)
0.21
2024-01-03
4
A
0
1000000
0
A
2034-01-03
Common Stock
1000000
1000000
D
25% of the grant vested on July 25, 2023, with the balance vesting in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) beginning at the end of August 2023 through July 2026.
The outstanding option was cancelled in exchange for a new option having a lower exercise price.
35,415 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through July 2026.
145,831 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through May 2027.
/s/ Tyler Blok
2024-01-05